Rezultati
eNauka >
Results >
A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3.
| Title: | A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3. | Authors  : | Zhang, Jianjun; ...; Andric, Zoran   ; ...; (broj, koautora 20) |
Issue Date: | 2025 | Publication: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X Journal of Clinical Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 43 br. 16_suppl str. TPS8664-TPS8664 | DOI: | 10.1200/JCO.2025.43.16_suppl.TPS8664 | WoS-ID: | 001690381400046 | URI: | https://enauka.gov.rs/handle/123456789/1031828 | Project: | Summit Therapeutics, Inc. | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.